NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, André P, Wagtmann N, Welters MJP, Kim YJ, Piersma SJ, van der Burg SH, van Hall T
Cell. 2018 175 (7): 1744-1755.e15

PMID: 30503208 · PMCID: PMC6354585 · DOI:10.1016/j.cell.2018.10.028

MeSH Terms (15)

Animals Antibodies, Neoplasm Antigens, CD Cancer Vaccines CD8-Positive T-Lymphocytes Cell Line, Tumor Histocompatibility Antigens Class I Humans Immunity, Cellular Integrin alpha Chains Mice Neoplasm Proteins Neoplasms, Experimental NK Cell Lectin-Like Receptor Subfamily C Vaccination

Connections (2)

This publication is referenced by other Labnodes entities:

Links